What is Waypoint Bio?
Waypoint Bio is at the forefront of developing advanced cell therapies, addressing the inherent trade-offs in traditional methods. The company's innovative platform enables both rapid and accurate in vitro analysis alongside high-quality in vivo assessments. By leveraging spatial biology technology, Waypoint Bio can meticulously measure cell-autonomous and non-autonomous effects, including cell-cell interactions and environmental influences. This sophisticated approach is poised to establish a new paradigm in the design and advancement of cell therapies, offering speed without compromising relevance and quality.
How much funding has Waypoint Bio raised?
Waypoint Bio has raised a total of $14.5M across 1 funding round:
Angel/Seed
$14.5M
Angel/Seed (2024): $14.5M with participation from Hummingbird Ventures, Fifty Years Industries, and Recode Health Ventures
Key Investors in Waypoint Bio
Hummingbird Ventures
Hummingbird Ventures is an Australian asset and investment management firm that specializes in listed equities, private equities, and real estate, with a focus on venture capital investments in technology companies.
Fifty Years Industries
Fifty Years is a pre-seed and seed-focused venture capital firm that supports founders utilizing technology to address major global challenges such as climate change, disease, and food systems.
Recode Health Ventures
Recode Health Ventures operates in the HR & Staffing industry, focusing on companies within the healthcare sector. It employs 20-49 people and generates between $1M-$5M in revenue.
What's next for Waypoint Bio?
The substantial enterprise-level funding and recent strategic investment signal a critical growth phase for Waypoint Bio. This capital infusion is expected to accelerate the company's research and development initiatives, potentially expanding its platform's applications and market reach. The focus on deep tech and addressing fundamental challenges in cell therapy development suggests a trajectory aimed at significant clinical and commercial milestones. Waypoint Bio's commitment to innovation positions it as a key player in the evolving landscape of biopharmaceutical development.
See full Waypoint Bio company page
